Literature DB >> 1704698

C reactive protein and immunoglobulin G in synovial fluid and serum in joint disease.

B Shine1, J T Bourne, F Begum Baig, J Dacre, D V Doyle.   

Abstract

C reactive protein (CRP) and immunoglobulin G (IgG) were measured in synovial fluid and serum of 72 patients (29 with rheumatoid arthritis (RA), 17 with osteoarthritis, 11 with crystal synovitis, seven with undifferentiated arthritis, and eight with seronegative arthritis). The synovial fluid:serum (SF:S) ratios were compared with those calculated from the SF:S ratios of transferrin, caeruloplasmin, and alpha 2 macroglobulin, using the binomial test within groups and the Mann-Whitney test between groups. In RA synovial fluid CRP concentrations were lower than expected and IgG concentrations higher than expected. In osteoarthritis CRP concentrations were higher than expected. In seronegative arthritis IgG concentrations were raised. The ratio of CRP:IgG was depressed in RA. These findings are consistent with a role for CRP in the inflammatory process of RA, while the CRP:IgG ratio may be of value in the differential diagnosis of joint disease.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1704698      PMCID: PMC1004321          DOI: 10.1136/ard.50.1.32

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  24 in total

1.  Assessment of rheumatoid activity based on clinical features and blood and synovial fluid analysis.

Authors:  M Farr; M J Kendall; D W Young; M J Meynell; C F Hawkins
Journal:  Ann Rheum Dis       Date:  1976-04       Impact factor: 19.103

2.  Platelet response to aggregated C-reactive protein: fibrinogen-dependent and independent signals.

Authors:  B A Fiedel
Journal:  Immunology       Date:  1988-01       Impact factor: 7.397

3.  IgG and IgM antibody to native type II collagen in rheumatoid arthritis serum and synovial fluid. Evidence for the presence of collagen-anticollagen immune complexes in synovial fluid.

Authors:  R B Clague; L J Moore
Journal:  Arthritis Rheum       Date:  1984-12

Review 4.  C-reactive protein: binding to lipids and lipoproteins.

Authors:  M B Pepys; I F Rowe; M L Baltz
Journal:  Int Rev Exp Pathol       Date:  1985

5.  Spontaneous and induced immunoglobulin secretion by synovial fluid B lymphocytes in rheumatoid arthritis.

Authors:  J Petersen; T Ingemann-Hansen; J S Halkjaer-Kristensen
Journal:  Ann Rheum Dis       Date:  1984-04       Impact factor: 19.103

6.  Evidence for local synthesis of antibodies to denatured collagen in the synovium in rheumatoid arthritis.

Authors:  M J Rowley; D J Williamson; I R Mackay
Journal:  Arthritis Rheum       Date:  1987-12

7.  Circulating human C-reactive protein binds very low density lipoproteins.

Authors:  I F Rowe; A K Soutar; I M Trayner; G R Thompson; M B Pepys
Journal:  Clin Exp Immunol       Date:  1984-10       Impact factor: 4.330

8.  The presence and possible significance of C-reactive protein in rheumatoid inflammation.

Authors:  J Highton; P A Hessian; D G Palmer
Journal:  J Rheumatol       Date:  1985-10       Impact factor: 4.666

9.  Comparative studies of serum and synovial fluid C reactive protein concentrations.

Authors:  I F Rowe; J Sheldon; P G Riches; A C Keat
Journal:  Ann Rheum Dis       Date:  1987-10       Impact factor: 19.103

10.  C-reactive protein mediates the solubilization of nuclear DNA by complement in vitro.

Authors:  F A Robey; K D Jones; A D Steinberg
Journal:  J Exp Med       Date:  1985-06-01       Impact factor: 14.307

View more
  7 in total

1.  The interaction of monoclinic calcium pyrophosphate dihydrate crystals with neutrophils.

Authors:  C I Winternitz; J K Jackson; H M Burt
Journal:  Rheumatol Int       Date:  1996       Impact factor: 2.631

2.  [Evidence-based recommendations for the management of undifferentiated peripheral inflammatory arthritis (UPIA). The German perspective on the international 3e initiative].

Authors:  I H Tarner; K Albrecht; M Fleck; E Gromnica-Ihle; G Keyßer; L Köhler; I Kötter; K Krüger; J Kuipers; H Nüßlein; A Rubbert-Roth; J Wollenhaupt; M Schneider; B Manger; U Müller-Ladner
Journal:  Z Rheumatol       Date:  2014-05       Impact factor: 1.372

3.  Comparative study of tetranectin levels in serum and synovial fluid of patients with rheumatoid arthritis, seronegative spondylarthritis and osteoarthritis.

Authors:  E F Kamper; L T Kopeikina; P Trontzas; N C Kyriazis; G Vaiopoulos; J Stavridis
Journal:  Clin Rheumatol       Date:  1998       Impact factor: 2.980

4.  Binding and surface exposure characteristics of the gonococcal transferrin receptor are dependent on both transferrin-binding proteins.

Authors:  C N Cornelissen; P F Sparling
Journal:  J Bacteriol       Date:  1996-03       Impact factor: 3.490

5.  Multinational evidence-based recommendations on how to investigate and follow-up undifferentiated peripheral inflammatory arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative.

Authors:  P Machado; I Castrejon; W Katchamart; R Koevoets; B Kuriya; M Schoels; L Silva-Fernández; K Thevissen; W Vercoutere; E Villeneuve; D Aletaha; L Carmona; R Landewé; D van der Heijde; J W J Bijlsma; V Bykerk; H Canhão; A I Catrina; P Durez; C J Edwards; M D Mjaavatten; B F Leeb; B Losada; E M Martín-Mola; P Martinez-Osuna; C Montecucco; U Müller-Ladner; M Østergaard; B Sheane; R M Xavier; J Zochling; C Bombardier
Journal:  Ann Rheum Dis       Date:  2010-08-19       Impact factor: 19.103

Review 6.  C-reactive protein in human atherogenesis: facts and fiction.

Authors:  Oliver Zimmermann; Kefei Li; Myron Zaczkiewicz; Matthias Graf; Zhongmin Liu; Jan Torzewski
Journal:  Mediators Inflamm       Date:  2014-04-01       Impact factor: 4.711

7.  The effect of robenacoxib on the concentration of C-reactive protein in synovial fluid from dogs with osteoarthritis.

Authors:  David Bennett; Peter David Eckersall; Mary Waterston; Veronica Marchetti; Alessandra Rota; Eilidh McCulloch; Silvia Sbrana
Journal:  BMC Vet Res       Date:  2013-03-01       Impact factor: 2.741

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.